2AtMay A, Yildiz-Demirtepe S, Tatlipinar S, et al. HLA-B51 gene and its expression in association with Behecet's Disease in Denizli Provine of Turkey[J]. Molecuar Biology Reports, 2008,35 (3) : 345- 349.
4Musabak U, Baylan O, Cetin T, et al. Lipid profile and anticardiolipin antibodies in Behcet's disrase[J]. Archives of Medical Research, 2005,36(4) :387-392.
5O. Shaker, M.A. Ay EI-Deen, H. E1 Hadidi, etal. The role of heat shock protein 60, vascular endothelial growth factor and antiphosphplipid antibodies in Beheet disease[J]. British Journal of Dermatology, 2007, 15(6): 32-37.
3International Study Group for Behct's disease. Criteria for diagnosis of Behqet's disease. Lancet, 1990, 335: 1078-1080.
4Lindquist K J, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol, 1971, 9: 753-760.
5Praprotnik S, Blank M, Meroni PL, et al Classification of antiendothelial cell antibodies against microvascular and macrovascular endothelial cells. Arthritis Rheum, 2001, 44, 1484-1494.
6Lee KH, Cho HI, Kim HS, et al. Activation of extracellular signal regadated kinase 1/2 in human dermal microvascular endothelial cells stimulated by anti-endothelial cell antibodies in sera of patients with Behcet's disease. J Dermatol Sci, 2002, 30: 63-72.
7Lee KH, Chung HS, Kim HS, et al. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum, 2003, 48: 2025-2035.
8Direskeneli H, Keser G, D' Cruz D, et al. Anti-endothelial cell antibodies, endothelial proliferation and yon Willebrand factor antigen in Behcet's disease. Clin Rheumatol, 1995, 14: 55-61.
9Koumantaki Y, Stavropoulos C, Spyropoulou M, et al. HLA-B^* 5101 in Greek patients with Behcet's disease. Hum Immunol, 1998, 59(4): 250-255.
10Verity DH, Wallace GR, Vaughan RW, et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease. Tissue Antigens, 1999, 54(3 ): 264-272.
